Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 67,836 | 295,357 | — | 500,000 | — | — |
| Cost of revenue | 64,147 | 219,939 | — | 323,388 | — | — |
| Gross profit | 3,689 | 75,418 | — | 176,612 | — | — |
| Research and development | 88,715 | 93,438 | — | 301,355 | 286,121 | — |
| Selling, general and administrative | 4M | 19M | — | 9M | 1M | — |
| Operating expenses | 4M | 19M | — | 9M | 2M | — |
| Operating income | −4M | −19M | — | −9M | −2M | — |
| Net income | −17M | −19M | −21M | −9M | −2M | −2M |
| Earnings per share | −0.20 | −0.54 | — | −0.34 | −0.08 | — |
| Earnings per share, diluted | −0.20 | −0.54 | — | −0.34 | −0.08 | — |
| Weighted average shares, diluted | 81M | 36M | — | 27M | 26M | — |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6M | 89,634 | 1M | — | 751,347 | 1M | 596,218 | — |
| Inventory | 2M | 1M |
| Metric | 31 Mar 2026 | 31 Mar 2025 |
|---|---|---|
| Operating cash flow | −8M | −1M |
| Depreciation and amortisation | 68,764 | 11,308 |
| Share-based compensation | 1M | 8M |
| Investing cash flow | −70,124 | — |
| Financing cash flow | 13M | 752,701 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 1M |
| — |
| — |
| 900,543 |
| — |
| — |
| Current assets | 9M | 1M | 3M | — | — | 2M | — | — |
| Property, plant and equipment | 1M | 1M | 701,633 | — | — | 109,664 | — | — |
| Total assets | 12M | 4M | 5M | — | — | 3M | — | — |
| Current liabilities | 8M | 11M | 4M | — | — | 6M | — | — |
| Total liabilities | 8M | 14M | 12M | — | — | 6M | — | — |
| Equity | 3M | −10M | −8M | −6M | −5M | −4M | −2M | −2M |
| Shares outstanding | 85M | 75M | 36M | — | — | 27M | — | — |
| Shares issued | 85M | 75M | 36M | — | — | 27M | — | — |